[Estrogen and progesterone receptors in endometrial carcinoma during high-dose progestogen (Depo-Provera) therapy].
D000230:Adenocarcinoma / Q000032:analysis / Q000188:drug therapy*; D004717:Endometrium / Q000032:analysis; D005260:Female; D006801:Humans; D008525:Medroxyprogesterone / Q000009:adverse effects / Q000031:analogs & derivatives*; D017258:Medroxyprogesterone Acetate; D011960:Receptors, Estrogen / Q000032:analysis; D011980:Receptors, Progesterone / Q000032:analysis; D014594:Uterine Neoplasms / Q000032:analysis / Q000188:drug therapy*
D011960:Receptors, Estrogen; D011980:Receptors, Progesterone; D017258:Medroxyprogesterone Acetate; D008525:Medroxyprogesterone
Az endometrium carcinoma oestrogén és progesteron receptorainak alakulása nagy dózisu progestogén (Depo-Provera) kezelésre.